Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
NASA’s Pandora telescope will study stars in detail to learn about the exoplanets orbiting them - 2Picking Childcare Administrations for Your Loved ones
- 3How does spider venom damage human cells? Researchers uncover the killer mechanism of recluse spider toxin
- 4Indoor Drinking Fountains: Famous Home Advancements during the Pandemic
- 5How to watch NASA's Artemis 2 astronauts launch to the moon on April 1
- Accor signs agreement to transform El Gouna resort as Sofitel
- Hilary Duff's husband responds to Ashley Tisdale's 'toxic' mom group claims: The drama, explained
- Washington state experiences historic flooding as Skagit River hits record high level. See flooding maps, highway closures and forecasts.
- Find the Specialty of Calligraphy: Dominating the Exquisite Art of Penmanship
- Excursion to Different Universes: the Top Sci-fi Motion pictures Ever
- 5 Most Expected Film Delivery
- Viable Tips for Seniors to Purchase a Minimal expense Jeep Wrangler
- Eleven arrested over mass shooting in South Africa tavern
- Moon memorial: Artemis 2 astronauts name lunar 'bright spot' after mission commander's late wife
